source
- Roche halts development of muscle-preserving obesity drug and returns program to ChugaiRoche announced it is ending work on the experimental muscle-building compound known as GYM329, which had been tested together with a GLP-1 based anti-obesity injection. The decision stops the ong…
- Azurity urges simpler medicines for children to reduce daily burdens on familiesAzurity Pharmaceuticals published a sponsored article that looks at how chronic medicines can shape a child's daily routine. The piece points out that while clinical trials test drugs under strict…